RNA, U6 small nuclear 855, pseudogene (RNU6-855P)

RNA, U6 small nuclear 855, pseudogene (RNU6-855P) is a processed pseudogene derived from the U6 small nuclear RNA gene family. U6 snRNAs are uridine-rich small noncoding RNAs essential for pre-mRNA intron splicing as part of the spliceosome complex[5][3]. In contrast, pseudogenes like RNU6-855P do not encode functional products due to accumulated disabling mutations or lack of necessary regulatory elements[2]. Processed pseudogenes arise by retrotransposition, and, although generally considered non-functional, some pseudogenes can influence gene regulation via RNA-mediated mechanisms such as miRNA sponging or acting as competing endogenous RNAs (ceRNAs). However, there are no specific functional or clinical roles described for RNU6-855P itself, and it is not considered a therapeutic target, receptor, enzyme, or biomarker[2][5]. Clarification: - RNU6-855P is not a functional RNA molecule but a genomic "fossil" of the U6 snRNA gene ("processed pseudogene")[2]. - It is not a direct target for drugs or therapy, nor does it function as an enzyme, transporter, transcription factor, or receptor[2][5]. - There are no reported drugs, biomarkers, or safety concerns uniquely associated with this specific pseudogene.

Other names

RNU6-855PU6-855PU6 snRNA pseudogene 855